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Caspase-3 dependent nitrergic 
neuronal apoptosis following 
cavernous nerve injury is mediated 
via RhoA and ROCK activation in 
major pelvic ganglion
Johanna L. Hannan1, Hotaka Matsui2, Nikolai A. Sopko3, Xiaopu Liu3, Emmanuel Weyne4, 
Maarten Albersen4, Joseph W. Watson3, Ahmet Hoke5, Arthur L. Burnett3 & 
Trinity J. Bivalacqua3
Axonal injury due to prostatectomy leads to Wallerian degeneration of the cavernous nerve (CN) and 
erectile dysfunction (ED). Return of potency is dependent on axonal regeneration and reinnervation 
of the penis. Following CN injury (CNI), RhoA and Rho-associated protein kinase (ROCK) increase 
in penile endothelial and smooth muscle cells. Previous studies indicate that nerve regeneration is 
hampered by activation of RhoA/ROCK pathway. We evaluated the role of RhoA/ROCK pathway in CN 
regulation following CNI using a validated rat model. CNI upregulated gene and protein expression of 
RhoA/ROCK and caspase-3 mediated apoptosis in the major pelvic ganglion (MPG). ROCK inhibitor 
(ROCK-I) prevented upregulation of RhoA/ROCK pathway as well as activation of caspase-3 in the 
MPG. Following CNI, there was decrease in the dimer to monomer ratio of neuronal nitric oxide 
synthase (nNOS) protein and lowered NOS activity in the MPG, which were prevented by ROCK-I. CNI 
lowered intracavernous pressure and impaired non-adrenergic non-cholinergic-mediated relaxation 
in the penis, consistent with ED. ROCK-I maintained the intracavernous pressure and non-adrenergic 
non-cholinergic-mediated relaxation in the penis following CNI. These results suggest that activation 
of RhoA/ROCK pathway mediates caspase-3 dependent apoptosis of nitrergic neurons in the MPG 
following CNI and that ROCK-I can prevent post-prostatectomy ED.
Despite nerve-sparing radical prostatectomy for the treatment of clinically localized prostate cancer, there is still 
a significant amount of men that develop severe erectile dysfunction (ED) post-surgical intervention1. The axonal 
injury which occurs is a classic peripheral neuropathy with an acute inflammatory phase leading to Wallerian 
degeneration of the autonomic nerves and an ultimate regenerative phase governed by enhanced neurotrophic 
factor activation and reduction in neuroinflammation2. Type 5 phosphodiesterase inhibitors (PDE5I) are utilized 
to treat post-RP ED1; however, PDE5I only affect corporal smooth muscle cell function and do not serve as a 
neurotrophic agent. Accumulating evidence suggests recovery of erectile function following injury to the cav-
ernous nerves (CN) is dependent, in part, upon axonal regeneration and successful functional reinnervation of 
the end-organ penis with intact neuronal nitric oxide (NO) release3. Therefore, novel targets are sought to assist 
erection recovery which focus on the protection of both vascular and more importantly, neuronal function.
The RhoA/Rho-associated protein kinase (ROCK) pathway plays an important NO-independent role in reg-
ulating smooth muscle tone in penile tissues and has off target effects on NO signaling in the penis4,5. Increased 
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activity of the RhoA/ROCK pathway is involved in several pathologic disease processes of the penis6–10. Following 
peripheral CN injury (CNI), membrane bound RhoA and ROCK increase in the corporal endothelial and smooth 
muscle cells of the penis11,12. This is associated with decreased nitrergic and endothelial nitric oxide synthase 
(NOS; nNOS and eNOS) protein expression and increased corporal tissue apoptosis4. The mechanisms hypoth-
esized to control the upregulation of penile RhoA and ROCK are thought to be secondary to denervation of 
the end-organ penis, increased adrenergic tone, and ischemia resulting from spontaneous tumescence. ROCK 
inhibition (ROCK-I) utilizing Y-27632 (a synthetic competitive inhibitor specific to ROCK1 and ROCK2) follow-
ing CNI improves erectile function via mechanisms directly related to restored NO-biosynthesis and decreased 
apoptosis in the penis11,12.
Although increased ROCK activity has been ascribed to cause increased penile vascular tone and ED, its role 
in regulation of autonomic CN function following injury has not been elucidated. In the central nervous system 
(CNS), RhoA/ROCK mediates growth inhibitory signals generated by myelin-associated inhibitors via growth 
factor stimulus of RhoA GTPase activity13–15. After CNS injury, RhoA and ROCK are activated which leads to 
cytoskeleton rearrangements of neurons, inhibition of neurite outgrowth and apoptosis16. In the peripheral nerv-
ous system (PNS), axonomy and injury upregulates transcription and translation of RhoA and ROCK, and phar-
macologic inhibition in vitro and in vivo increases axonal regeneration following peripheral nerve injury17–19. 
Taken together, these studies indicate that peripheral regeneration is hampered by concurrent activation of the 
regenerative brake RhoA.
The role of the RhoA/ROCK signaling cascade in the major pelvic ganglia (MPG) and the peripheral auto-
nomic CN following injury is unknown. In this study, we demonstrate that upregulation of the RhoA/ROCK 
pathway in the MPG leads to direct activation of caspase-3 and selective apoptosis of nitrergic neurons. Using a 
validated pre-clinical model to study the peripheral effects of CNI11,12, we demonstrate that inhibition of ROCK 
will prevent apoptosis in the MPG, and restore nitrergic signaling to the penis thus preventing the detrimental 
effects of axonal degeneration to the penis that occur after CNI.
Results
Impact of CNI on MPG RhoA/ROCK and neuronal marker gene and protein expression. Early 
temporal increases in RhoA, ROCK1 and ROCK2 mRNA expressions were evident 48 hours to 14 days after CNI 
and decreased by 30 days post-CNI (Fig. 1A–C). The gene expressions of markers for nitrergic (nNOS), parasym-
pathetic (ChAT), sympathetic (TH) neurons and the neuronal marker (β IIITub) were decreased by 50% within 
48 hours of CNI (Fig. 1D–F,I). Interestingly, the gene expression of these markers increased, peaked at 14–21 days 
and remained 50% lower than sham at 30–60 days. The mRNA expression of GFAP, a marker of Schwann cells, 
was markedly increased 48 hours to 21 days after CNI (Fig. 1G). GAP43, a marker of neuronal growth, peaked 
14 days subsequent to bilateral CNI and fell below sham levels (Fig. 1H). Increases in the protein expression of 
ROCK1 and ROCK2 was also evident 48 hours to 14 days post-CNI (Fig. 2A–C). Representative images of immu-
nofluorescence staining demonstrate localization of RhoA in the cavernous nerve as well as the MPG neuronal 
cell body and nucleolus (Fig. 2D–I). ROCK1 and ROCK2 staining is primarily located in the neuronal cell bodies 
following CNI.
CNI increased caspase-3 mediated apoptosis in MPG. The number of TUNEL-positive apoptotic cells 
was increased in the MPG 7 and 14 days post-CNI (Fig. 3A,B). The increased apoptosis occurred in parallel with 
increased MPG gene expression of caspase 1 and 3 between 48 hours and 21 days post-CNI (Fig. 3C,D). There 
was no change in the mRNA expression of caspase 9 (Fig. 3E). A positive correlation in gene expression of RhoA, 
ROCK1 or ROCK2 to caspase 3 mRNA was observed indicating that an upregulation of RhoA, ROCK1, and 
ROCK2 correlates with the increase in apoptosis in the MPG after CNI.
ROCK-I prevents RhoA/ROCK mediated caspase activation. Elevated gene expressions of RhoA, 
ROCK1 and ROCK2 14 days following CNI were prevented by ROCK-I in the MPG (Fig. 4A–C). Following CNI, 
the MPG activity of RhoA GTPase and total ROCK activity was 2-fold higher than sham and inhibition of ROCK 
prevented the increased activity of both RhoA GTPase and total ROCK activity (Fig. 4D,E). The CNI-induced 
increase in gene expression of caspase 3 was also prevented by treatment with a ROCK inhibitor (Fig. 4F). 
Western blot analysis of total and activated caspase 3 showed an increase in the ratio of total to activated caspase 
3 protein in CNI 14d MPGs which was significantly lower following ROCK inhibition (Fig. 4G,H).
nNOS uncoupling is prevented with ROCK-I. The production of NO occurs when nNOS is in its dimer-
ized form and when uncoupled can lead to diminished levels of NO and increased oxidative stress20. Following 
CNI injury, there is decrease in the dimer to monomer ratio of nNOS protein, decreased mRNA expression 
and lowered nNOS activity in the MPG (Fig. 5A–C). Additionally, immunofluorescence staining demonstrates a 
qualitative decrease in nNOS positive ganglionic cell bodies (Fig. 5D–F). Treatment with ROCK-I prevents the 
uncoupling of nNOS and increases the gene expression of nNOS and the activity of nNOS. There is an increase in 
the number of nNOS positive ganglionic cells compared to CNI MPG with ROCK-I.
Increased neurite outgrowth with ROCK inhibition. Fourteen days after CNI, sham, CNI, and CNI 
rodents treated with Y-27632 were sacrificed. The MPGs were then explanted and cultured in Matrigel. Neurite 
outgrowth in cultured MPGs was measured after 48 hours of incubation. There was no difference in average neu-
rite length in the sham and CNI MPGs (Fig. 6A,B). MPGs cultured in Matrigel from injured rats treated with the 
ROCK-I demonstrated increased neurite outgrowth in comparison to sham and CNI MPGs (p < 0.05, Fig. 6A,B).
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In vivo erectile function and ex vivo corporal vasorelaxation is preserved by ROCK-I. As pre-
viously shown21, CNI leads to significantly lower ICP/MAP, maximal ICP and total ICP (Fig. 7A–C). Further 
evidence of dysfunctional nitrergic signaling is evident by a decline in the NANC-mediated relaxation in the 
penis from CNI rats at all frequencies (Fig. 7D). ROCK-I prevented the deficit in erectile function post-CNI and 
maintained total ICP, ICP/MAP, and total ICP to levels observed in the age-matched sham cohort (Fig. 7A–C). 
Additionally, NANC-mediated relaxation of corporal tissue at all frequencies tested was also preserved with the 
inhibition of ROCK (Fig. 7D).
Discussion
In the present study, the in vivo erectile responses and ex vivo corporal relaxation results demonstrated that 14 
days after bilateral CNI there is a profound decline in nitrergic-nerve mediated erectile responses and corporal 
vasorelaxation. Identification of alternative pathways contributing to nitrergic axonal degeneration is necessary 
to advance therapeutic strategies for ED particularly those related to nerve injury and neurological diseases. Thus, 
we evaluated the activation and expression of RhoA and ROCK in the MPG following CNI in an effort to identify 
a disease-specific inhibitors of axonal regeneration that contribute to early degeneration of the autonomic inner-
vation of the penis in response to peripheral CNI. The results of the present study demonstrate an early sustained 
temporal increase in expression of RhoA and ROCK in the MPG after CNI. This increase in gene expression and 
activation of RhoA and ROCK in the MPG directly correlated with apoptosis in the MPG measured by TUNEL 
positive cells and caspase 3 gene expression. We also demonstrate that nNOS positive ganglion and gene expres-
sion is significantly decreased following bilateral CNI in the MPG. We found that nNOS is uncoupled contrib-
uting to the decreased expression and activity of nNOS in the MPG 14 days following bilateral CNI. These data 
identify RhoA/ROCK as a potential novel signaling pathway activated in response to CNI, which may serve as a 
regulator of peripheral nitrergic (nNOS) axonal degeneration.
There is a desperate need for understanding evolving mechanisms of neuronal degeneration and regener-
ative pathways in the MPG and CNs after iatrogenic injury. The animal model chosen for this study was a CN 
crush injury since this type of peripheral nerve injury is designed to mimic the partial nerve damage that occurs 
Figure 1. Time course of gene expression of RhoA/ROCK and neuronal markers in the MPG following 
CNI. The gene expressions of RhoA (A), ROCK1 (B), ROCK2 (C), markers for nitrergic (nNOS, D), 
parasympathetic (ChAT, E), sympathetic (TH, F) neurons and the neuronal marker β IIITub (G), markers for 
nitrergic (nNOS, D), parasympathetic (ChAT, E), sympathetic (TH, F) neurons, neuronal marker β IIITub (G), 
a marker of Schwann cells (GFAP, H) and marker of neuronal growth (GAP43, I) were measured. Each bar 
represents mean ± SEM normalized to the mRNA relative expression of HPRT1 (n = 6–8/group). * P < 0.05 
compared to Sham.
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during nerve-sparing radical prostatectomy. The model of bilateral CNI causes a time-dependent decline in neu-
rogenic erectile response to CN stimulation and is the model validated22 for studying mechanisms-associated 
with post-CNI ED (post-prostatectomy ED).
RhoA is a small GTP-binding protein, acting as a molecular switch between the inactive GDP-bound state 
and the active GTP-bound state23. The major downstream effector of RhoA is ROCK1 and ROCK2, which serve 
as key regulators of penile vascular homeostasis and upon activation cause ED4. However, the role in regulation 
of neuronal autonomic innervation to the penis from the MPG is unknown and identification of inhibitory sign-
aling pathways in the MPG after CNI has not been investigated. Recently, an increase in RhoA and ROCK2 was 
observed in the MPG in a type 1 diabetic rodent model24 suggesting that in a disease state, which is associated 
with neuropathy, RhoA and ROCK may mediate peripheral autonomic neuropathy of the penis. In the present 
study, we found a peak in expression and activity of RhoA and both ROCK isoforms in the MPG 14 days post CNI 
providing evidence that a temporal increase in RhoA and ROCK contributes to the loss of autonomic ganglion 
cells (nNOS, TH, and ChAT) of the MPG. The localization of RhoA/ROCK expression was found in both the 
ganglion cell bodies and nerve fibers. These findings implicate that RhoA/ROCK may influence CN function.
An interesting finding from this study was the rapid decrease in gene expression of nNOS, TH, and ChAT 
with a temporal increase in expression peaking at 14–21 days with another significant decline in expression in 
the MPG at 30 and 60 days post-injury. This change in expression follows the temporal trend in expression of the 
house keeping gene β -tubulin III at the same time points. Previously, we have demonstrated that in vivo neuro-
genic erectile responses to CN stimulation following injury have a time-dependent decline in erectile function 
with the most significant decline at 14 days and improvement in neurogenic-mediated erections up to 60 days 
post injury21. Prior studies have shown the importance of Schwann cell activation in peripheral nerve regenera-
tion25,26. The duration of their involvement was previously unknown. We demonstrate increased GFAP expression 
in the MPG for all time points up to 21 days following injury suggesting they are involved in early nerve remode-
ling. Taken together, the results of the present study and previous investigations suggest that despite improvement 
in physiologic erections there is genomic changes in autonomic ganglion and neurons which is lower (~50% fold 
change) than age-matched rat MPG but there is still continued regeneration of nerves which provide adequate 
innervation to the penis to restore normal penile homeostasis.
Bilateral CNI reduced nNOS expression in the dorsal nerve of the penis as a result of neurodegeneration 
following neuropraxia27. We have previously demonstrated that ROCK-I prevented a decline in nNOS expres-
sion in CNI rat penes11. The preservation of nNOS levels and neurogenic-mediated erectile responses indicate 
that the autonomic innervation to the corpora cavernosa is conserved in animals treated with ROCK-I. RhoA/
ROCK signaling pathway is activated in neural tissue following nerve injury and ischemia in the central nervous 
Figure 2. Protein expression and immunofluorescent localization of RhoA/ROCK signaling proteins in 
the MPG. Representative images for Western blots of ROCK1, ROCK2 and α -actin (A). Quantification was 
performed by densitometry, normalized to α -actin and expressed as a percentage of Sham (B,C). Each bar 
represents mean ± SEM (n = 6/group). * P < 0.05 compared to Sham. (D) Paraffin-embedded sections were 
stained with RhoA, ROCK1 or ROCK2 (red), β III tubulin (green) and nuclear stain DAPI (blue). Magnification 
200x.
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system13–15. Activation of ROCK can inhibit axon elongation and result in growth cone collapse in regenerating 
neurons15. Here we show an increase in RhoA, ROCK1 and ROCK2 gene and protein expression as well as RhoA 
GTPase and total ROCK activity in the MPG 14 days post CNI. Thus, inhibition of ROCK may promote CN 
regeneration following peripheral crush injury. In the present study, we found a number of novel findings: CNI 
results in a reduction in nitrergic (nNOS) gene expression, uncoupling of nNOS protein with resultant decline in 
nNOS enzymatic activity, and decreased axonal staining of nNOS in the MPG 14 days after CNI. Moreover, we 
show that inhibition of ROCK with Y-27632 prevents the uncoupling of nNOS and increases nNOS gene expres-
sion and activity in the MPG. This directly results in preserved neurogenic mediated in vivo and ex vivo nitrergic 
relaxation of the corpora cavernosa thus providing direct evidence for RhoA and ROCK inhibitory function on 
nitrergic axons of the MPG.
Activation of RhoA/ROCK following peripheral nerve injury has been shown to inhibit neurite outgrowth in 
spinal motor and peripheral sensory neurons28. We’ve demonstrated that MPGs cultured in Matrigel from CNI 
rats treated with Y-27632 have increased neurite sprouting and growth. Explanted MPGs from Y-27632-treated 
BCNI rats demonstrated decreased RhoA staining, which is consistent with prior studies. In several tissue types, 
including motor neurons, ROCK-I has been shown to decrease its upstream regulator RhoA29–32. This feedback 
inhibition may further augment nerve regeneration and contribute to the increased neuritogenesis from the MPG 
following ROCK inhibition seen in our model. The specific types of neurites (adrenergic, cholinergic, nitrergic), 
which show increased growth from the MPG, are unknown at this time and will be the focus of future exploratory 
studies.
Figure 3. CNI induced an increase in TUNEL positive cells, and caspase-1 and -3 in the MPG that was 
significantly correlated with the gene expression of RhoA/ROCK. TUNEL positive stained cells (white 
arrows, A) were counted from control and CNI MPGs and normalized to the cross-sectional area of the MPG 
(B; n = 6/group). The mRNA expression of caspase-1 (C), -3 (D), and -9 (E) was normalized to HPRT1 gene 
expression and bars represent the mean ± SEM. * P < 0.05 compared to Sham. Scatter diagrams demonstrate the 
correlation between MPG caspase-3 gene expression levels and RhoA (F), ROCK1 (G) and ROCK2 (H) gene 
expression levels from Sham and all injured time points. R = Spearman correlation coefficient.
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The intrinsic capability of adult peripheral neurons to regenerate is accompanied by a non-permissive envi-
ronment consisting of soluble inhibitory molecules, which counteract a regenerative response and promote 
apoptosis. Recent evidence demonstrates that activation of RhoA and ROCK in peripheral nerves inhibits neu-
rogenesis after injury17 and based on our previous11,12 and current study we clearly show that activation of RhoA/
ROCK occurs in the MPG after CNI and represents a novel signaling pathway that inhibits neurite outgrowth 
after injury. Here we show that inhibition of ROCK prevents nitrergic degeneration in the MPG, promotes neu-
ritogenesis of MPG neurites ex vivo and preserved autonomic innervation to the penis. The mechanism by which 
this occurs appears to be related to inhibition of caspase-3 dependent apoptosis of ganglia in the MPG. We have 
previously shown using a whole genomic microarray that pro-apoptotic genes, including caspase-1 and 3, are 
activated early (48 hours) and 14 days post CNI in the MPG33. In the present study, we show that TUNEL-positive 
apoptotic cells increase in the MPG 7 and 14 days post-CNI with an associated increase in gene expression of both 
caspase 1 and 3 between 48 hours and 21 days post-injury. We also demonstrated that activated caspase-3 protein 
expression is increased 14 days after injury. Of particular interest is the observation that a positive correlation in 
gene expression of RhoA and ROCK to caspase 3 in the MPG which strongly suggesting that the RhoA/ROCK 
signaling axis mediates the increase in apoptosis in the MPG after CNI. This is further supported by the effect of 
Figure 4. Treatment with Y-27632 lowered the RhoA/ROCK and caspase-3 gene expression and activity 
of CNI MPGs to sham levels. Gene expression of RhoA (A), ROCK1 (B) and ROCK2 (C) was lowered with 
ROCK-I. Similarly, ROCK-I prevented elevated RhoA GTPase activity (D) and total ROCK activity (E) caused 
by CNI. Elevated gene expression of caspase-3 was also prevented by treatment with a ROCK inhibitor (F). 
Western blot analysis of caspase-3 control cell extracts treated with or without cytochrome c were used to 
confirm full length and cleaved activated caspase 3 (G). Quantification was performed by densitometry and 
expressed as the ratio of total caspase-3 to activated caspase-3 (H). Each bar represents mean ± SEM. Gene 
expression data were normalized to the mRNA relative expression of HPRT1. * P < 0.05 compared to Sham. 
ΨP < 0.05 compared to CNI 14d.
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ROCK-I prevents caspase-3 dependent apoptosis 14 days post-CNI. These results are consistent with previous 
reports in the CNS by which inhibition of ROCK prevented apoptosis via a capse-3 dependent mechanism14,34.
Previously, in both the CNS and PNS, the use of ROCK-I (fasudil, Y-27632) enhance axonal regeneration with 
improvement in motor function16. Consistent with the results from our ex vivo explanted MPG, we found that 
daily systemic administration of Y-27632 for 11 days with a three day wash out period to avoid direct vascular 
effects preserved erectile responses to CN stimulation in vivo and ex vivo corporal myograph responsiveness to 
activation of NANC nerves that was similar to age-matched sham rats. The CNI group had significantly impaired 
end organ penile vascular function consistent with a peripheral neuropathy. Systemic ROCK-I prevented both 
RhoA GTPase activity and total ROCK activity in the MPG and decreased RhoA and ROCK gene expression 
14 days after CNI. We chose the 14 day post-crush time point in our peripheral CNI model for all physiologic, 
molecular, and biochemical analysis in order to evaluate a time when axonal degeneration and early axonal regen-
eration is occurring with end organ target re-innervation21. Y-27632 is a non-selective ROCK inhibitor and the 
specific isoform of ROCK responsible for the pathologic effects observed in this study cannot be assessed; how-
ever, it’s unlikely that one isoform is more detrimental in this experimental model since both ROCK1 and 2 are 
increased following CNI.
Figure 5. ROCK-I prevented nNOS uncoupling and preserved nNOS gene expression and activity in the 
MPGs of CNI rats. CNI uncoupled nNOS protein and lead to decreased dimer to monomer ratio (A) and 
lower relative nNOS mRNA expression (B). Y-27632 prevented nNOS uncoupling and increased nNOS gene 
expression. Western blot quantification was performed by densitometry, normalized to GAPDH and gene 
expression was normalized to the relative expression of HRPT1. Each bar represents mean ± SEM (n = 6/
group). * P < 0.05 compared to sham and ΨP < 0.05 to CN14d. NOS activity assessed by measuring L-citrulline 
production was lowered in CNI14d MPGs and maintained at sham levels with ROCK inhibition (C). Paraffin-
embedded sections stained with nNOS (red), β III tubulin (green) and nuclear stain DAPI (blue) demonstrated a 
decrease in nNOS positive ganglion cell bodies following CNI which was prevented with ROCK inhibition (D). 
Magnification 200x.
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Figure 6. ROCK-I increased neurite outgrowth from the MPG of CNI rats. (A) Photomicrograph 
demonstrating neurite outgrowth from sham, CNI, and CNI + Y-27632 treated rats 14 days post-injury. The 
MPG were explanted and grown in Matrigel and neurite length was quantified 48 hours after explant. (B) Bar 
graphs demonstrating neurite length (μ m) from the three groups of MPG explanted and grown in Matrigel. 
Each bar represents mean ± SEM (n = 3/group). * P < 0.05 compared to Sham and CNI.
Figure 7. Erectile function and NANC-mediated relaxation was preserved in CNI rats treated with 
Y-27632. Inhibition of ROCK prevented the decline in ICP/MAP (A), maximal ICP (B) and total ICP (area 
under the curve, C) after CNI. Additionally, CNI decreased electrical field stimulated NANC-mediated 
relaxation and ROCK inhibition prevented the decline in relaxation (D). Each bar represents mean ± SEM 
(n = 8/group). * P < 0.05 compared to Sham. ΨP < 0.05 compared to CNI14d.
www.nature.com/scientificreports/
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While in vivo and ex vivo penile hemodynamics and corporal responsiveness were preserved following daily 
treatment with the selective ROCK-I, Y-27632, one limitation is that it remains undetermined whether this is a 
beneficial physiologic effect that can be found after an established injury has occurred to CN and MPG. Moreover, 
can a delay in treatment with a ROCK-I also promote regeneration of nitrergic axons with reversal of the auto-
nomic neuropathy to the penis? Further studies examining the role of the RhoA/ROCK pathway in the MPG and 
penile innervation are ongoing in our laboratory to address this question. Also, the upstream activators of RhoA, 
such as local induction of macrophages and myelin-associated molecules, glycoproteins or chondroitin sulphate 
proteoglycans (CSPGs) following injury were not addressed in this study and warrant further investigation35.
Besides its pertinence to the field of ED, the study of RhoA/ROCK signaling in axonal degeneration of the CN 
following crush injury carries additional implications with regard to the field of peripheral axonal regeneration. 
Knowledge gained in the present study of activated RhoA in the neuroregulation of penile erection provides the 
first scientific evidence of therapeutic inhibitors of ROCK demonstrating benefit on peripheral nerve regenera-
tion via mechanisms involving inhibition of caspase-3 dependent apoptosis and prevention of nitrergic degener-
ation in the MPG following peripheral CN-injury.
Conclusions
The results of this study indicate that RhoA/ROCK signaling cascade in the MPG promotes apoptosis and 
nitrergic dysfunction following CNI. Furthermore, systemic administration of the pharmacologic inhibitor of 
ROCK (Y-27632) prevents caspase-3 dependent apoptosis of nNOS positive axons, nNOS uncoupling and enzy-
matic activity in the MPG. Inhibition of ROCK promoted neuritogenesis from explanted MPG and preserved 
nitrergic nerve mediated erections and corporal relaxation in the penis. Therefore, we believe ROCK-I may 
be an important target to preserve axonal autonomic innervation to the penis following nerve-sparing radical 
prostatectomy.
Materials and Methods
Experimental design. All experiments were approved by the Johns Hopkins University School of Medicine 
Animal Care and Use Committee in accordance with the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals. Male Sprague-Dawley rats (Charles River, Wilmington, MA) weighing 300–325 grams 
were used and housed in 12 h light/dark lighting cycle with free access to food and water.
The first experiment randomly assigned 128 rats to 7 groups to undergo sham or bilateral cavernous nerve 
injury (CNI) surgery. Subsequent to surgery, MPG tissue was collected for histological analysis, Western blotting, 
PCR and activity assays after 48 hours, 7, 14, 21, 30 and 60 days (Table 1).
The second experiment used 96 rats to examine the effects of ROCK-I on CNI. Animals were assigned to 
sham, CNI or CNI plus twice daily intraperitoneal (IP) injections with ROCK inhibitor Y-27632 (5 mg/kg; Tocris 
Bioscience, Ellisville, MO, USA). ROCK-I was withdrawn 72 hours prior to erectile function testing and tissue 
collection 14 days post-CNI (Table 1).
CNI and sham surgeries. Under anesthesia, the prostate was exposed via a midline laparotomy and CN 
identified11,12,36. CNI was induced by applying forceps for 15 seconds x 3 to the nerve 2–3 mm distal to the MPG37. 
In sham animals the CN were identified and the abdomen closed.
Quantitative PCR (qPCR). MPGs from sham, 48 hour, 7, 14, 21, 30, 60 day rats were homogenized and 
total RNA was extracted and purified using the RNeasy system (Qiagen, Hilden, Germany), quantified and 
then reverse transcribed (GE Healthcore, Pittsburgh, PA, USA)21. Real-time qPCR was performed using the 
StepOnePlus system (Applied Biosystems, Foster City, CA, USA). TaqMan gene expression assays for RhoA, 
ROCK1, ROCK2, nNOS, choline ester transferase (ChAT), tyrosine hydroxylase (TH), type 3 beta-tubulin 
Experiment 1
Groups qPCR (n = 56)
Western blots 
(n = 42) Histology (n = 30) Total (n = 128)
Sham 8 7 5 20
BCNI 48 h 8 7 5 20
BCNI 7d 8 7 5 20
BCNI 14d 8 7 5 20
BCNI 21d 8 8
BCNI 30d 8 7 5 20
BCNI 60d 8 7 5 20
Experiment 2
Groups qPCR (n = 24) Western blots (n = 21)
Histology & 
Matrigel (n = 15)
Activated RhoA 
GTPase (n = 18)
Total ROCK 
Activity (n = 18) Total (n = 96)
Sham 8 7 5 6 6 32
BCNI 14d 8 7 5 6 6 32
BCNI 14d + Y-27632 8 7 5 6 6 32
Table 1.  Treatment and control rodent groups used in experiments.
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(β IIITub), glial factor activating protein (GFAP), growth associated protein 43 (GAP43), caspase-1, caspase-3, 
caspase-9, activating transcription factor 3 (ATF3) and hypoxanthine phosphoribosyltransferase 1 (HPRT1) were 
used (Applied Biosystems). HPRT1 was unchanged and served as an endogenous control. All experiments were 
performed in triplicate (n = 8/group).
Western blotting. MPGs were excised and homogenized in a Tris-HCL (pH 7.5) buffer to evaluate the 
protein level of ROCK1 and ROCK2 by Western blot12. Sol-O-Buffer (Fabgenix, Frisco, TX) was used to assay 
nNOS monomers and dimers in the MPG under non-reducing conditions38. Protein (30 μ g) was loaded on a 
4–12% NuPage Bis-Tris gel (Invitrogen, Carlbad, CA) and separated by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). Electrophoresis was done at 4 °C for nNOS monomers and dimers. Proteins were transferred to pol-
yvinylidene fluoride membranes and incubated with primary antibodies (ROCK1, ROCK2 (1:1000, Santa Cruz 
Biotechnology, Santa Cruz, CA), total casapse-3, activated caspase-3 (1:1000 Cell Signaling, Beverly, MA), nNOS 
(1:200 Santa Cruz), GAPDH (1:2500 BD Bioscience) and actin (1:500 (Sigma Aldrich, St. Louis, MO)) overnight 
at 4 °C. The membranes were incubated with a horseradish peroxidase-linked secondary antibody and visualized 
using an enhanced chemiluminescence kit (Amersham). The densitometry results were quantified using software 
Image J (National Institutes of Health) and normalized by actin level37.
Histologic analysis. The same animals were used for histological analysis and MPG culture with one 
MPG going to each experimental procedure. MPGs were formalin fixed and immunofluorescence staining was 
performed as previously described37. Primary antibodies assessed were RhoA, ROCK1, ROCK2 (1:400, Santa 
Cruz Biotechlogy, Santa Cruz, CA), nNOS (1:50, BD Bioscience, Franklin Lakes, NJ), β IIITub (1:500, Abcam, 
Cambridge, UK). Secondary antibodies were Alexa-488- and Alexa-594-conjugated (1:200; Invitrogen) and 
nuclei were stained with 4′ ,6-diamidino-2-phenylindole (DAPI; Invitrogen). A separate set of slides were stained 
for TUNEL as per manufacturer’s instructions (ApopTag Peroxidase In Situ Apoptosis Detection Kit, Millipore) 
and counter stained with Hematoxylin (Vector Laboratories, Burlingame, CA). The counting of apoptotic cells 
was performed by 2 blinded individuals and normalized to the total area of the MPG.
Total ROCK, RhoA GTPase and nNOS activity assays. A separate group of MPGs were homogenized 
and total ROCK activity was analyzed in MPG lysate with of 0.1 mM adenosine triphosphate by a ROCK activity 
assay kit using peroxidase coupled anti-phospho-MYPT1 Thr696 monoclonal antibody (CyClex, Nagano, Japan). 
RhoA GTPase activity was assayed in MPG lysates by 96-well activity assays (Cytoskeleton, Denver, Colorado) 
according to manufacturer specifications. Total ROCK and RhoA GTPase activity are displayed as a percent of 
sham activity, as previously described8,12.
NOS activity in MPG tissues was assessed by radiolabeled L-arginine to L-citrulline conversion as previously 
described (Cayman, Chemical, Ann Arbor, MI, USA)8,39. Constitutive NOS activity measurements were per-
formed in the presence of calcium and shown as a fold change from sham MPG values.
MPG Culture and Neurite Outgrowth Assessment. Whole MPGs were excised and embedded on 
reduced growth factor Matrigel in serum free media (RPMI 1640 with 1% Penicillin-Streptomycin, GIBCO) as 
described (n = 3/group)21. All MPGs were covered with 1 ml of media with VEGF (vascular endothelial growth 
factor; 25 μ g/ml, R&D Systems, Minneapolis, MN, USA) which was changed every 24 hours and maintained at 
37 °C in a humidified atmosphere with 5% CO2. Photographs of neurite growth were captured 48 h following 
implantation using a Nikon TE200 inverted microscope attached to a CCD Camera and digital images were 
analyzed with Elements software (Nikon Instruments, Melville, NY, USA). In each area of growth from the MPG 
the 5 longest neurites were measured21. The averages of these measurements defined the neurite length for each 
groups (20–25 neurites measured per MPG).
Erectile function measurement. Under anesthesia, the left crus was cannulated with a 25 G needle 
connected to a pressure transducer to measure intracavernous pressure (ICP)37. The right carotid artery was 
cannulated for continuous measurement of mean arterial pressure (MAP). The CN distal to the crush injury 
was stimulated with a square pulse stimulator (Grass Instruments, Quincy, MA, USA) at a frequency of 20 Hz, 
0.5 msec duration, pulse width of 30 seconds at 4 volts for one minute. Outcome parameters used were ICP/MAP, 
peak ICP, and total ICP (area under the curve, AUC)21.
Myograph tissue bath experiments. The penis was cleaned of the urethra, dorsal vessels and nerves, cut 
in 2 × 10 mm strips and mounted in a muscle strip myograph (DMT, Denmark)40. Strips were placed in a phys-
iological salt solution, bubbled with 95% O2/5% CO2 at 37 °C, stretched 4–5 mN, and equilibrated for an hour41. 
Non-adrenergic, non-cholinergic (NANC) mediated relaxation was assessed by electrical field stimulation (EFS) 
in penile strips incubated with atropine (3 × 10−5 M, Sigma) and guanethidine (10−5 M, Sigma) for 30 mins. Strips 
were precontracted with phenylephrine (10−5 M) and stimulated at 40 V, 3-ms pulse width at increasing frequen-
cies (1–64 Hz) for 10 sec with 2 min between stimuli. EFS responses were measured as percent relaxation from the 
pre-contraction to phenylephrine.
Statistical Analysis. Data were expressed as mean ± SEM. Differences between multiple groups were com-
pared by analysis of variance (ANOVA) followed by a Tukey’s multiple comparisons test. Two-group analysis was 
performed by unpaired t-test. P values of less than 0.05 were used as criteria for statistical significance.
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